RESEARCH-USE BIOSIMILAR ANTIBODY
Ligufalimab
Monoclonal antibody · IgG4
Ligufalimab (AK 117) is a humanized IgG4 anti-CD47 monoclonal antibody. Ligufalimab does not induce RBC hemagglutination, and induces phagocytosis. Ligufalimab shows anti-tumor activity.
TARGETIAP
YMonoclonal antibody
CATALOGSC-BS-419
CATALOG NUMBERSC-BS-419
MOLECULAR WEIGHTApprox. 144.58 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ligufalimab (AK 117) is a humanized IgG4 anti-CD47 monoclonal antibody. Ligufalimab does not induce RBC hemagglutination, and induces phagocytosis. Ligufalimab shows anti-tumor activity.
Ligufalimab is a recombinant research-use antibody directed against IAP.